BCG vaccination to prevent tuberculosis in health care workers: A decision analysis

Preventive Medicine

Volumn 26, Issue 2, 1997, Pages 201-207

  Marcus, Alexander M ^a   Rose, David N ^a   Sacks, Henry S ^a   Schechter, Clyde B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bacille Calmette Guerin; BCG; health care worker; isoniazid; occupational health; prevention; tuberculin; tuberculosis; vaccination

Indexed keywords

BCG VACCINE; ISONIAZID; TUBERCULIN;

ARTICLE; BCG VACCINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEPATITIS; HIGH RISK POPULATION; HUMAN; META ANALYSIS; MORTALITY; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0031104866     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1996.0123     Document Type: Article

References (46)

1. Sepkowitz K A. Tuberculosis and the health care worker: a historical perspective. Ann Intern Med. 120:1994;71-79.
2. ten Dam H G. BCG vaccination. Tuberculosis: a comprehensive international approach. 1993;Dekker, New York. p. 251-274.
3. MMWR. 40:1991;585-591.
4. Fischl M A, Uttamchandani R B, Daikos G L. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 117:1992;177-183.
5. Edlin B R, Tokars J I, Grieco M H. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 326:1992;1514-1521.
6. Pearson M L, Jereb J A, Frieden T R. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med. 117:1992;191-196.
7. Dooley S W Jr, Castro K G, Hutton M D, Mullan R J, Polder J A, Snider D E Jr. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR. 39:1990;1-29.
8. MMWR. 43:1994;1-132.
9. Blumberg H M, Watkins D L, Berschling J D. Preventing the nosocomial transmission of tuberculosis. Ann Intern Med. 122:1995;658-663.
10. Maloney S A, Pearson M L, Gordon M T, Del Castillo R, Boyle J F, Jarvis W R. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med. 122:1995;90-95.
11. Wenger P N, Otten J, Breeden A, Dawn O, Beck-Sague C M, Jarvis W R. Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among health care workers and HIV-infected patients. Lancet. 345:1995;235-240.
12. Ferguson R G. BCG vaccination in hospitals and sanatoria of Saskatchewan: a study carried out by the National Research Council of Canada. Am Rev Tuberc. 54:1946;325-339.
13. Comstock G W. Field trials of tuberculosis vaccines: how could we have done them better. Controlled Clin Trials. 15:1994;247-276.
14. Fine P EM, Rodrigues L C. Modern vaccines: mycobacterial diseases. Lancet. i:1990;1016-1020.
15. Indian J Med Res. 72:1980;1-74.
16. Colditz G A, Brewer T F, Berkey C S. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA. 271:1994;698-702.
17. Brewer T F, Colditz G A. Bacille Calmette-Guérin vaccination for the prevention of tuberculosis in health care workers. Clin Infect Dis. 20:1995;136-142.
18. Markowitz S B. Epidemiology of tuberculosis among health care workers. Occup Med. 9:1994;589-608.
19. Comstock G W, Livesay V T, Woolpert S F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 124:1974;1-16.
20. Comstock G W, Cauthen G M. Epidemiology of tuberculosis. Reichman L B, Hershfield E S. Tuberculosis: a comprehensive international approach. 1993;23-48 Dekker, New York.
21. Combs D L, O'Brien R J, Geiter L J. USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, and acceptability. Ann Intern Med. 112:1990;397-406.
22. Cohn D L, Catlin B J, Peterson K L, Judson F N, Sbarbaro J A. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: a twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med. 112:1990;407-415.
23. Rodrigues L C, Diwan V K, Wheeler J G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 22:1993;1154-1158.
24. Lotte A, Wasz-Höckert O, Poisson N, Domitrescu N, Verron M, Covet E. BCG complications: estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res. 21:1984;107-193.
25. Lotte A, ten Dam H G, Henderson R. BCG complications: second IUATLD study on complications induced by intradermal BCG-vaccination. Bull Int Union Tuberc Lung Dis. 63:1988;47-83.
26. Bull WHO. 60:1982;555-564.
27. Ferebee S H. Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv Tuberc Res. 17:1970;28-106.
28. Kopanoff D E, Snider D E Jr, Caras G J. Isoniazid-related hepatitis. Am Rev Respir Dis. 117:1978;991-1001.
29. Rose D N, Schechter C B, Silver A L. The age threshold for isoniazid chemoprophylaxis: a decision analysis for low-risk tuberculin reactors. JAMA. 256:1986;2709-2713.
30. MMWR. 45:1996;1-18.
31. Brewer T F, Colditz G A. Relationship between Bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. Clin Infect Dis. 20:1995;126-135.
32. Goble M, Iseman M D, Madsen L A, Waite D, Ackerman L, Horsburgh C R Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 328:1993;527-532.
33. Ruben F L, Norden C W, Schuster N. Analysis of a community hospital employee tuberculosis screening program 31 months after its inception. Am Rev Respir Dis. 115:1977;23-28.
34. Geiseler P J, Nelson K E, Crispen R G. Tuberculosis in physicians: compliance with preventive measures. Am Rev Respir Dis. 135:1987;3-9.
35. Aitken M L, Anderson K M, Albert R K. Is the tuberculosis screening program of hospital employees still required. Am Rev Respir Dis. 136:1987;805-807.
36. Selwyn P A, Hartel D, Lewis V A. A prospective study of the risk of tuberculosis among injection drug users with human immunodeficiency virus infection. N Engl J Med. 320:1989;545-550.
37. Daley C L, Small P M, Schecter G F. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment length polymorphisms. N Engl J Med. 326:1992;231-235.
38. Dooley S W, Villarino M E, Lawrence M. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA. 267:1992;2632-2635.
39. von Reyn C F, Clements C J, Mann J M. Human immunodeficiency virus infection and routine childhood immunization. Lancet. ii:1987;669-672.
40. Onorato I M, Markowitz L E, Oxtoby M J. Childhood immunization, vaccine-preventable diseases and infection with human immunodeficiency virus. Pediatr Infect Dis J. 6:1988;588-595.
41. Quinn T C. Interactions of the human immunodeficiency virus and tuberculosis and the implications for BCG vaccination. Rev Infect Dis. 11:1989;S379-S384.
42. ten Dam H G. BCG vaccination and HIV infection. Bull Int Union Tuberc Lung Dis. 65:1990;38-39.
43. Harries A D. Tuberculosis and human immunodeficiency virus in developing countries. Lancet. ii:1990;387-390.
44. Weltman A C, Rose D N. The safety of Bacille-Calmette-Guérin vaccination in HIV infection and AIDS. AIDS. 7:1993;149-157.
45. Greenberg P D, Lax K G, Schechter C B. Tuberculosis in house staff: a decision analysis comparing the tuberculin screening strategy with the BCG vaccination. Am Rev Respir Dis. 143:1980;490-495.
46. Reichman L B, Jordan T J. Decision analysis comparing the tuberculin screening strategy with BCG vaccine. Am Rev Respir Dis. 145:1992;732-732.